|
1
|
Miller ME, Rejeski WJ, Messier SP and
Loeser RF: Modifiers of change in physical functioning in older
adults with knee pain. The Observational Arthritis Study in Seniors
(OASIS). Arthritis Rheum. 45:331–339. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Palazzo C, Nguyen C, Lefevre-Colau MM,
Rannou F and Poiraudeau S: Risk factors and burden of
osteoarthritis. Ann Phys Rehabil Med. 59:134–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Loeser RF, Goldring SR, Scanzello CR and
Goldring MB: Osteoarthritis: A disease of the joint as an organ.
Arthritis Rheum. 64:1697–1707. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pulsatelli L, Addimanda O, Brusi V,
Pavloska B and Meliconi R: New findings in osteoarthritis
pathogenesis: Therapeutic implications. Ther Adv Chronic Dis.
4:23–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thysen S, Luyten FP and Lories RJ:
Targets, models and challenges in osteoarthritis research. Dis
Model Mech. 8:17–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lawrence RC, Felson DT, Helmick CG, Arnold
LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG,
et al: Estimates of the prevalence of arthritis and other rheumatic
conditions in the United States: Part II. Arthritis Rheum.
58:26–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng DS and Visco CJ: Pharmaceutical
therapy for osteoarthritis. PM R. 4 5 Suppl:S82–S88. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pelletier JP, Martel-Pelletier J and
Abramson SB: Osteoarthritis, an inflammatory disease: Potential
implication for the selection of new therapeutic targets. Arthritis
Rheum. 44:1237–1247. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goldring MB and Otero M: Inflammation in
osteoarthritis. Curr Opin Rheum. 23:471–478. 2011. View Article : Google Scholar
|
|
10
|
Haywood L, McWilliams DF, Pearson CI, Gill
SE, Ganesan A, Wilson D and Walsh DA: Inflammation and angiogenesis
in osteoarthritis. Arthritis Rheum. 48:2173–2177. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
López-Armada MJ, Caramés B, Lires-Deán M,
Cillero-Pastor B, Ruiz-Romero C, Galdo F and Blanco FJ: Cytokines,
tumor necrosis factor-alpha and interleukin-1beta, differentially
regulate apoptosis in osteoarthritis cultured human chondrocytes.
Osteoarthritis Cartilage. 14:660–669. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mengshol JA, Vincenti MP, Coon CI,
Barchowsky A and Brinckerhoff CE: Interleukin-1 induction of
collagenase 3 (matrix metalloproteinase 13) gene expression in
chondrocytes requires p38, c-jun N-terminal kinase, and nuclear
factor kappaB: Differential regulation of collagenase 1 and
collagenase 3. Arthritis Rheum. 43:801–811. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pujol JP, Chadjichristos C, Legendre F,
Bauge C, Beauchef G, Andriamanalijaona R, Galera P and Boumediene
K: Interleukin-1 and transforming growth factor-beta1 as crucial
factors in osteoarthritic cartilage metabolism. Connect Tissue Res.
49:293–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Melusova M, Slamenova D, Kozics K, Jantova
S and Horvathova E: Carvacrol and rosemary essential oil manifest
cytotoxic, DNA-protective and pro-apoptotic effect having no effect
on DNA repair. Neoplasma. 61:690–699. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bakır M, Geyikoglu F, Colak S, Turkez H,
Bakır TO and Hosseinigouzdagani M: The carvacrol ameliorates acute
pancreatitis-induced liver injury via antioxidant response.
Cytotechnology. 68:1131–1146. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Z, Hua C, Pan X, Fu X and Wu W:
Carvacrol exerts neuroprotective effects via suppression of the
inflammatory response in middle cerebral artery occlusion rats.
Inflammation. 39:1566–1572. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Akhtar N, Rasheed Z, Ramamurthy S,
Anbazhagan AN, Voss FR and Haqqi TM: MicroRNA-27b regulates the
expression of matrix metalloproteinase 13 in human osteoarthritis
chondrocytes. Arthritis Rheum. 62:1361–1371. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marcu KB, Otero M, Olivotto E, Borzi RM
and Goldring MB: NF-kappaB signaling: Multiple angles to target OA.
Curr Drug Targets. 11:599–613. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martel-Pelletier J, Boileau C, Pelletier
JP and Roughley PJ: Cartilage in normal and osteoarthritis
conditions. Best Pract Res Clin Rheumatol. 22:351–384. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aida Y, Maeno M, Suzuki N, Shiratsuchi H,
Motohashi M and Matsumura H: The effect of IL-1beta on the
expression of matrix metalloproteinases and tissue inhibitors of
matrix metalloproteinases in human chondrocytes. Life Sci.
77:3210–3221. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li H, Li L, Min J, Yang H, Xu X, Yuan Y
and Wang D: Levels of metalloproteinase (MMP-3, MMP-9), NF-kappaB
ligand (RANKL), and nitric oxide (NO) in peripheral blood of
osteoarthritis (OA) patients. Clin Lab. 58:755–762. 2012.PubMed/NCBI
|
|
23
|
Marcu KB, Otero M, Olivotto E, Borzi RM
and Goldring MB: NF-kappaB signaling: Multiple angles to target OA.
Curr Drug Targets. 11:599–613. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Landa P, Kokoska L, Pribylova M, Vanek T
and Marsik P: In vitro anti-inflammatory activity of carvacrol:
Inhibitory effect on COX-2 catalyzed prostaglandin E(2)
biosynthesis. Arch Pharm Res. 32:75–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Silva FV, Guimarães AG, Silva ER,
Sousa-Neto BP, Machado FD, Quintans-Júnior LJ, Arcanjo DD, Oliveira
FA and Oliveira RC: Anti-inflammatory and anti-ulcer activities of
carvacrol, a monoterpene present in the essential oil of oregano. J
Med Food. 15:984–991. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lima Mda S, Quintans-Júnior LJ, de Santana
WA, Martins Kaneto C, Pereira Soares MB and Villarreal CF:
Anti-inflammatory effects of carvacrol: Evidence for a key role of
interleukin-10. Eur J Pharmacol. 699:112–117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arigesavan K and Sudhandiran G: Carvacrol
exhibits anti-oxidant and anti-inflammatory effects against 1,
2-dimethyl hydrazine plus dextran sodium sulfate induced
inflammation associated carcinogenicity in the colon of Fischer 344
rats. Biochem Biophys Res Commun. 461:314–320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vincenti MP and Brinckerhoff CE: Early
response genes induced in chondrocytes stimulated with the
inflammatory cytokine interleukin-1beta. Arthritis Res. 3:381–388.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen WP, Tang JL, Bao JP, Hu PF, Shi ZL
and Wu LD: Anti-arthritic effects of chlorogenic acid in
interleukin-1β-induced rabbit chondrocytes and a rabbit
osteoarthritis model. Int Immunopharmacol. 11:23–28. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han G, Shao H, Zhu X, Wang G, Liu F, Wang
F, Ling P and Zhang T: The protective effect of xanthan gum on
interleukin-1β induced rabbit chondrocytes. Carbohydr Polym.
89:870–875. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakagawa S, Arai Y, Mazda O, Kishida T,
Takahashi KA, Sakao K, Saito M, Honjo K, Imanishi J and Kubo T:
N-acetylcysteine prevents nitric oxide-induced chondrocyte
apoptosis and cartilage degeneration in an experimental model of
osteoarthritis. J Orthop Res. 28:156–163. 2010.PubMed/NCBI
|
|
32
|
Aktan F: iNOS-mediated nitric oxide
production and its regulation. Life Sci. 75:639–653. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abramson SB: The role of COX-2 produced by
cartilage in arthritis. Osteoarthritis Cartilage. 7:380–381. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ying X, Chen X, Cheng S, Shen Y, Peng L
and Xu HZ: Piperine inhibits IL-β induced expression of
inflammatory mediators in human osteoarthritis chondrocyte. Int
Immunopharmacol. 17:293–299. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chowdhury TT, Bader DL and Lee DA: Dynamic
compression counteracts IL-1beta induced iNOS and COX-2 activity by
human chondrocytes cultured in agarose constructs. Biorheology.
43:413–429. 2006.PubMed/NCBI
|
|
36
|
Aristatile B, Al-Assaf AH and Pugalendi
KV: Carvacrol suppresses the expression of inflammatory marker
genes in D-galactosamine-hepatotoxic rats. Asian Pac J Trop Med.
6:205–211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dreier R, Grässel S, Fuchs S, Schaumburger
J and Bruckner P: Pro-MMP-9 is a specific macrophage product and is
activated by osteoarthritic chondrocytes via MMP-3 or a
MT1-MMP/MMP-13 cascade. Exp Cell Res. 297:303–312. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takaishi H, Kimura T, Dalal S, Okada Y and
D'Armiento J: Joint diseases and matrix metalloproteinases: A role
for MMP-13. Curr Pharm Biotechnol. 9:47–54. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fosang AJ, Last K, Knäuper V, Murphy G and
Neame PJ: Degradation of cartilage aggrecan by collagenase-3
(MMP-13). FEBS Lett. 380:17–20. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Johansson N, Saarialho-Kere U, Airola K,
Herva R, Nissinen L, Westermarck J, Vuorio E, Heino J and Kähäri
VM: Collagenase-3 (MMP-13) is expressed by hypertrophic
chondrocytes, periosteal cells, and osteoblasts during human fetal
bone development. Dev Dyn. 208:387–397. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ahmed S, Wang N, Hafeez BB, Cheruvu VK and
Haqqi TM: Punica granatum L. extract inhibits IL-1beta-Induced
expression of matrix metalloproteinases by inhibiting the
activation of MAP kinases and NF-kappaB in human chondrocytes in
vitro. J Nutr. 135:2096–2102. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Aida Y, Maeno M, Suzuki N, Shiratsuchi H,
Motohashi M and Matsumura H: The effect of IL-1beta on the
expression of matrix metalloproteinases and tissue inhibitors of
matrix metalloproteinases in human chondrocytes. Life Sci.
77:3210–3221. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Woodell-May J, Matuska A, Oyster M, Welch
Z, O'Shaughnessey K and Hoeppner J: Autologous protein solution
inhibits MMP-13 production by IL-1β and TNFα-stimulated human
articular chondrocytes. J Orthop Res. 29:1320–1326. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liacini A, Sylvester J, Li WQ and
Zafarullah M: Inhibition of interleukin-1-stimulated MAP kinases,
activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappaB)
transcription factors down-regulates matrix metalloproteinase gene
expression in articular chondrocytes. Matrix Biol. 21:251–262.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Saklatvala J: Inflammatory signaling in
cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use
of inhibitors for research into pathogenesis and therapy of
osteoarthritis. Curr Drug Targets. 8:305–313. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Roman-Blas JA and Jimenez SA: NF-kappaB as
a potential therapeutic target in osteoarthritis and rheumatoid
arthritis. Osteoarthritis Cartilage. 14:839–848. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wehling N, Palmer GD, Pilapil C, Liu F,
Wells JW, Müller PE, Evans CH and Porter RM: Interleukin-1beta and
tumor necrosis factor alpha inhibit chondrogenesis by human
mesenchymal stem cells through NF-kappaB-dependent pathways.
Arthritis Rheum. 60:801–812. 2009. View Article : Google Scholar : PubMed/NCBI
|
